Generic Name
CEFRADINE Capsules 0.25g

Reg. No.
 (1) 12 Capsules：HC20020012；(2) 20 Capsules：HC20050009；(3) 24 Capsules：HC20050009 

Indication
 Cefradine is indicated for use primarily in the treatment of infections of the respiratory and genitourinary tracts and skin and soft tissue caused by susceptible organisms as listed below: Staphylococcal infections(including infections caused by both penicillinase– producing and non-penicillinase-producing strains): Abscess, furunculosis, bronchitis and impetigo. Streptococcal infections(beta-haemolytic): Cellulitis, pneumonia, tonsillitis, otitis media, pharyngitis, sinusitis, scarlet fever, septic sore throat and urinary tract infections. Pneumococcal infections: Lobar pneumonia, bronchitis, cellulitis and otitis media. E.Coli infections: Abscess and urinary tract infections. Klebsiella infections: Lobar pneumonia and urinary tract infections. 

Specification
 0.25g/Capsule 

Package
 Blister packaging，12 Capsules、20 Capsules or 24 Capsules/Small Box. 

Manufacture
 Hong Kong